ChemicalBook
Chinese English Germany Korean

ShangHai Biochempartner Co.,Ltd 企業の連絡先情報

名前:ShangHai Biochempartner Co.,Ltd
電話番号:177-54423994
電子メール:2853530910@QQ.com
国籍:China
ウェブサイト:www.biochempartner.com
商品の合計数:8000
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

製品カタログ

Ozoralizumabオゾラリズマブ（遺伝子組換え）1167985-17-2
Pateclizumab1202526-59-7
Sirukumabシルクマブ（遺伝子組換え）1194585-53-9
Biotinyl Cystamine128915-82-2C14H26N4O2S3
AMG-131N-[3,5-ジクロロ-4-[(3-キノリル)オキシ]フェニル]-2,4-ジクロロベンゼンスルホンアミド315224-26-1C21H12Cl4N2O3S
AZ322288709-96-4C20H16N4O
NCC0072342583-66-6C22H28F3N7
Apostatin-12559703-06-7C19H27N3OS
NCGC00378430920650-00-6C22H23N3O5S
2,4-Dichlorophenoxyacetyl chloride(2,4-ジクロロフェノキシ)酢酸クロリド774-74-3C8H5Cl3O2
Dectrekumab1528523-94-5
Nemolizumab1476039-58-3
Lirilumab1000676-41-4
Tesidolumab1531594-08-7
Onartuzumabオナルツズマブ（遺伝子組換え）1133766-06-9
Ponezumab1178862-65-1
Radretumab1253180-81-2
Tregalizumab1207446-68-1
Ublituximab1174014-05-1
Urelumab934823-49-1
Solitomab1005198-65-1
Quilizumab1228538-47-3
Patritumab1262787-83-6
Vatelizumab1238217-55-4
Tabalumabタバルマブ（遺伝子組換え)1143503-67-6
Ficlatuzumab1174900-84-5
Narnatumab1188275-92-4
Crenezumabクレネズマブ（遺伝子組換え）1095207-05-8
Blosozumab1132758-87-2
Clazakizumab1236278-28-6
Fasinumabファシヌマブ（遺伝子組換え）1190239-42-9
Enoticumab1192578-27-0
Duligotuzumab1314238-96-4
Demcizumab1243262-17-0
Vesencumab1205533-60-3
Caplacizumabカプラシズマブ（遺伝子組換え）915810-67-2
Flanvotumab1188277-05-5
Inclacumab1256258-86-2
Indatuximab Ravtansine1238517-16-2
Futuximab1310460-85-5
Imgatuzumab959963-46-3
Ligelizumabリゲリズマブ（遺伝子組換え）1322627-61-1
Bezlotoxumabベズロトクスマブ（遺伝子組換え）1246264-45-8
Actoxumab1245634-25-6
Vandortuzumab Vedotin1471985-92-8
Evinacumabエビナクマブ（遺伝子組換え）1446419-85-7
Lokivetmab1533403-95-0
Tafasitamab1422527-84-1
Isatuximabイサツキシマブ（遺伝子組換え）1461640-62-9
Lacutamab2187368-16-5
Andecaliximab1518996-49-0
SUC-ALA-ALA-PRO-PHE-PNA107409-54-1C30H34N6O8
Amivantamabアミバンタマブ（遺伝子組換え）2171511-58-1
Indusatumab Vedotin1514889-12-3
ML3392579689-83-9C26H32ClN3O5
Mc-Val-Ala-PAB-PNP1639939-40-4C32H37N5O10
YTX-4652225824-53-1C25H26N6O3
Bocidelpar2095128-20-2C25H27F3N2O3
SR16644′-[5-[[(S)-1-(4-ニトロフェニル)エチル]アミノカルボニル]-2,3-ジメチル-1H-インドール-1-イルメチル]-1,1′-ビフェニル-2-カルボン酸1338259-05-4C33H29N3O5
RY7851393748-80-5C21H20N4O2S
JYN423461903742-34-6C27H24BrN7O3
AZD-1940881413-29-2C20H29F2N3O2S
INE9632640567-43-5C19H26N6O2S
GI 1817713-[3-[1-[2-オキソ-2-(イソプロピルフェニルアミノ)エチル]-2,4-ジオキソ-5-フェニル-2,3,4,5-テトラヒドロ-1H-1,5-ベンゾジアゼピン-3α-イル]ウレイド]安息香酸305366-98-7C34H31N5O6
(R)-GSK-36850322170140-50-6C22H24N6OS
SCD1 inhibitor-31282606-48-7C19H16FN7O2
JQKD-822410512-38-6C27H40N4O5
BioE-11971268863-69-9C20H18FN3O2
Zunsemetinib1640282-42-3C25H22ClF2N5O3
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione1380532-27-3C10H11F3N2O5
FTO-IN-32585198-87-2C12H10N4OS
SBI-4251451272-71-1C13H12ClN3O4S
OTX 008286936-40-1C52H72N8O8
YM150ダレキサバン365462-23-3C27H30N4O4
Ro60-0175Ro-60-0175169675-08-5C11H12ClFN2
2,4-Imidazolidinedione, 5-[3-[[4-[(3-methylphenyl)methoxy]phenyl]thio]-2-furanyl]-877176-23-3C21H18N2O4S
MRTX17192630904-45-7C23H18ClFN6O2
TH54272253744-56-6C20H20Cl2N8O3
Sigma-1 receptor antagonist 21639220-15-7C20H26ClN3O2
GSK2512125968-05-8C29H37FN6O4S
Erucinエルシン4430-36-8C6H11NS2
Ensitrelvir fumarate2757470-18-9C22H17ClF3N9O2.C4H4O4
Boc-Val-Ala-PAB-PNP1884578-00-0C27H34N4O9
1-Piperidinamine, N-hydroxy-N-nitroso-56329-24-9C5H11N3O2
Tamtuvetmab1608122-71-9
Blontuvetmab1608112-78-2
Enoblituzumab1353485-38-7
Refanezumab1233953-61-1
Mirvetuximab1453084-36-0
Satralizumabサトラリズマブ（遺伝子組換え）1535963-91-7
Cabiralizumab1613144-80-1
Xentuzumab1417158-65-6
Olendalizumab1337966-73-0
Tilavonemab2096513-89-0
Tisotumab1418628-81-5
Rovalpituzumab1613313-01-1
Ifabotuzumab1234137-51-9
Rinucumab1569263-06-4
Risankizumabリサンキズマブ（遺伝子組換え）1612838-76-2
Afasevikumab1589503-30-9
64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2017 © ChemicalBook. All rights reserved